About N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate (PubChem CID 160660103) has the molecular formula C93H96F3N23O5
and a molecular weight of 1672.94 g/mol. Its IUPAC name is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate.
Frequently Asked Questions
What is the IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The IUPAC name of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate (CID 160660103) is N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate.
What is the SMILES notation for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The canonical SMILES for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate is COC(=O)C1CCC(c2nc(-c3cc4cccc(C)c4[nH]3)c3c(N)ncnn23)CC1.COCC(=O)NCC1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1.Nc1nccn2c(C3CCC(CNC(=O)c4cccc(C(F)(F)F)c4)CC3)nc(-c3cc4ccccc4[nH]3)c12.Nc1ncnc2c1c(-c1cc3ccccc3[nH]1)cn2CC1CC1.
What is the InChIKey of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
The InChIKey is RLODLDGZFCLDJS-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H27F3N6O.C24H28N6O2.C22H24N6O2.C18H17N5/c30-29(31,32)21-6-3-5-20(14-21)28(39)35-16-17-8-10-18(11-9-17)27-37-24(25-26(33)34-12-13-38(25)27)23-15-19-4-1-2-7-22(19)36-23;1-32-14-20(31)27-13-15-6-8-16(9-7-15)24-29-21(22-23(25)26-10-11-30(22)24)19-12-17-4-2-3-5-18(17)28-19;1-12-4-3-5-15-10-16(26-17(12)15)18-19-20(23)24-11-25-28(19)21(27-18)13-6-8-14(9-7-13)22(29)30-2;19-17-16-13(15-7-12-3-1-2-4-14(12)22-15)9-23(8-11-5-6-11)18(16)21-10-20-17/h1-7,12-15,17-18,36H,8-11,16H2,(H2,33,34)(H,35,39);2-5,10-12,15-16,28H,6-9,13-14H2,1H3,(H2,25,26)(H,27,31);3-5,10-11,13-14,26H,6-9H2,1-2H3,(H2,23,24,25);1-4,7,9-11,22H,5-6,8H2,(H2,19,20,21).
What are the key properties of N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate?
N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate has a molecular weight of 1672.94 g/mol, XLogP of 16.86, 17 rotatable bonds, 10 hydrogen bond donors, and 22 hydrogen bond acceptors.
Where does this data come from?
All data for N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-2-methoxyacetamide;N-[[4-[8-amino-1-(1H-indol-2-yl)imidazo[1,5-a]pyrazin-3-yl]cyclohexyl]methyl]-3-(trifluoromethyl)benzamide;7-(cyclopropylmethyl)-5-(1H-indol-2-yl)pyrrolo[2,3-d]pyrimidin-4-amine;methyl 4-[4-amino-5-(7-methyl-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl]cyclohexane-1-carboxylate is sourced from PubChem (CID 160660103), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).